تاثیر قابل ملاحظه ویتامین دی در بهبود اختلال عملکرد بطنی در بیماران تالاسمی وابسته به تزریق خون
Remarkable Efficacy of Vitamin D in Improving Ventricular Dysfunction in Transfusion-Dependent Thalassemia Patients.
نویسندگان: احمد جامعی خسروشاهی , عزیز حسن زاده , امیر عطااله هیرادفر
کلمات کلیدی: Cardiac dysfunction, Thalassemia, Ventricular Dysfunction, Vitamin D
نشریه: 16586 , 8 , 4 , 2018
| نویسنده ثبت کننده مقاله |
امیر عطااله هیرادفر |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات سلامت کودکان |
| کد مقاله |
69104 |
| عنوان فارسی مقاله |
تاثیر قابل ملاحظه ویتامین دی در بهبود اختلال عملکرد بطنی در بیماران تالاسمی وابسته به تزریق خون |
| عنوان لاتین مقاله |
Remarkable Efficacy of Vitamin D in Improving Ventricular Dysfunction in Transfusion-Dependent Thalassemia Patients. |
| ناشر |
4 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Abstract
Background: The purpose of this study was to investigate efficacy of high dose vitamin D in improving left
ventricular ejection fraction (LVEF) in thalassemia patients with heart failure and vitamin D deficiency.
Materials and Methods: This clinical trial study was conducted on 16 chronically transfused thalassemia
patients and ventricular dysfunction with vitamin D deficiency between December and Jun 2018 in Thalassemia
clinic, Tabriz Children Hospital. Mean age of the patients was 11.15 ± 3.61 years ranged from 8 to 18 years old.
A serum 25-hydroxy vitamin D3 (25-OHD3) level less than 30ng/dl was considered vitamin D deficiency in this
study. LVEF less than 55% was indicated as poor pump function. The patients received 50,000 IU of vitamin
D3 weekly for 8 weeks. Data on LVEF and serum 25-OHD3 were compared before and after completing the
treatment. Moreover, adverse effects were recorded during the study.
Results: Means of serum 25-OHD3 levels, before and after the study, were 13.10±5.91ng/ml and
51.03±4.31ng/ml, respectively (p=0.01). Means of LVEF were13.10±5.91% and 50.27±11.93% before and after
the study, respectively (p=0.03). Means of serum ferritin levels were 3913±2229 ng/ml (ranged from 1246
to11000ng/ml). Mean of cardiac magnetic resonance imaging (MRI) T2* of the patients was 11.51±5.34ms.
Serum parathyroid hormone (PTH) levels of the patients decreased from the beginning of the study to the end of
the eighth week (94.28 ± 18.35 vs 43.66 ± 17.31ng/ml) (p=0.03). There was a positive correlation between mean
of serum 25-OHD3 level and cardiac MRI T2* parameter at the beginning of the study (r=0.001). There was a
positive correlation between in the increase of mean serum 25-OHD3 and LVEF percent at the end of study
(r=0.001).
Conclusion: Results showed that vitamin D3 was effective and safe in improving LVEF and cardiac
dysfunction in transfusion-dependent thalassemia patients with vitamin D deficiency. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| SSU-v8n4p228-en.pdf | 1398/07/07 | 245451 | دانلود |